Rallybio
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Rallybio
Rallybio Corporation, founded on March 22, 2018, in Delaware, is a clinical-stage biotechnology company led by seasoned biopharmaceutical industry experts with extensive experience in research, development, and rare diseases. The company's mission is to develop and commercialize transformative therapies for patients suffering from serious and rare conditions. Since its inception in January 2018, Rallybio has built a robust and promising pipeline of candidate product therapies aimed at addressing unmet medical needs in areas including maternal and fetal health, complement dysregulation, hematology, and metabolic disorders. Among its leading programs currently in clinical development are RLYB212, an anti-HPA-1a antibody designed to prevent fetal and neonatal alloimmune thrombocytopenia (FNAIT), and RLYB116, a complement component 5 (C5) inhibitor with the potential to treat various complement dysregulation diseases. Company website: http://www.rallybio.com Company address: 234 Church Street Suite 1020 New Haven, CT 06510
How to Buy Rallybio (RLYB)
Sign In
1-Minute Account Opening
Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.
Deposit funds
Once your account has been verified, you can deposit funds into your account using your preferred payment method.
Buy RLYB
Search for RLYB via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.